论文部分内容阅读
Introduction Mobilisation of hematopoietic peripheral blood stem cell (PBSC) represent a standard procedure in patients prior to an autologous stem cell transplant.Starting 2008,the biosimilars GCSF were granted with EU licence for mobilisation of PBSC.